XV7-41472-57413

4 vaccinations 12 coded responses 51 check-ins 11 free-text entries 2 call cases

Sex: Female
Age at first dose: 56-60
ZIP prefix: 761 / TX
Registered: 2021-05-13

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-13
Registered in v-safe
2021-05-13
Dose 1 — Pfizer-BioNTech
2021-05-13
Survey response — 0 day, dose 1
MedDRA: Hypoaesthesia oral — Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-05-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Nausea

Adult check-in
2021-05-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches, Nausea

Adult check-in
2021-05-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea, Diarrhea

Adult check-in
2021-05-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness, Nausea

Adult check-in
2021-05-20
Health check-in — 7 day, dose 1
Feeling: Good · Fever · Fatigue or tiredness, Nausea

Adult check-in
2021-05-27
Survey response — 14 day, dose 1
MedDRA: Injection site pruritus, Injection site rash, Injection site warmth, Self-medication — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-05-27
Report sent to call center — 14 day, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-03
Health check-in — 21 day, dose 1
Feeling: Fair

Adult check-in
2021-06-10
Dose 2 — Pfizer-BioNTech
2021-06-11
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school

Adult check-in
2021-06-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-06-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-06-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-06-15
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site bruising — Feeling: Fair · Site: Redness, Swelling · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-06-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Redness, Swelling · Fatigue or tiredness

Adult check-in
2021-06-17
Health check-in — 7 day, dose 2
Feeling: Good · Site: Redness, Swelling · Fatigue or tiredness

Adult check-in
2021-06-24
Health check-in — 14 day, dose 2
Feeling: Good

Adult check-in
2021-07-01
Survey response — 21 day, dose 2
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-07-10
Survey response — 28 day, dose 2
MedDRA: Oesophagitis — Feeling: Fair

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-07-15
Health check-in — 35 day, dose 2
Feeling: Good

Adult check-in
2021-07-23
Health check-in — 42 day, dose 2
Feeling: Fair

Adult check-in
2021-09-09
Survey response — 3 month, dose 2
MedDRA: Condition aggravated, Hyperparathyroidism, Pre-existing disease — Feeling: Fair

MedDRA releases: 2024-11 · check-in answers available
2021-12-09
Survey response — 6 month, dose 2
MedDRA: Arthralgia, Myalgia — Feeling: Fair

MedDRA releases: 2024-11 · check-in answers available
2022-03-04
Dose 3 — Pfizer-BioNTech
2022-03-04
Survey response — 0 day, dose 3
MedDRA: Immediate post-injection reaction, Tongue disorder — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2022-03-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-03-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-03-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches

Adult check-in
2022-03-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2022-03-09
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Nausea

Adult check-in
2022-03-10
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Nausea

Adult check-in
2022-03-11
Health check-in — 7 day, dose 3
Feeling: Fair · Headache

Adult check-in
2022-03-18
Health check-in — 14 day, dose 3
Feeling: Good

Adult check-in
2022-03-25
Survey response — 21 day, dose 3
MedDRA: Muscle spasms, Oesophagitis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2022-04-01
Health check-in — 28 day, dose 3
Feeling: Good

Adult check-in
2022-04-08
Survey response — 35 day, dose 3
MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2022-04-15
Health check-in — 42 day, dose 3
Feeling: Good

Adult check-in
2022-04-28
Call successful
Does not wish to fill out VAERS report
2022-06-03
Health check-in — 3 month, dose 3
Feeling: Good

Adult check-in
2022-09-02
Health check-in — 6 month, dose 3
Feeling: Good

Adult check-in
2022-11-12
Dose 4 — Pfizer-BioNTech
2022-11-12
Survey response — 0 day, dose 4
MedDRA: Hypoaesthesia oral — Feeling: Fair · Site: Pain, Swelling · Headache

MedDRA releases: 2024-11 · check-in answers available
2022-11-13
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-11-14
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain, Redness, Swelling · Headache

Adult check-in
2022-11-15
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-11-16
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain, Swelling · Headache

Adult check-in
2022-11-17
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-11-19
Health check-in — 7 day, dose 4
Feeling: Good · Muscle or body aches, Nausea

Adult check-in
2022-11-26
Health check-in — 14 day, dose 4
Feeling: Good

Adult check-in
2022-12-03
Health check-in — 21 day, dose 4
Feeling: Fair

Adult check-in
2022-12-10
Health check-in — 28 day, dose 4
Feeling: Good

Adult check-in
2022-12-17
Health check-in — 35 day, dose 4
Feeling: Fair

Adult check-in
2022-12-24
Health check-in — 42 day, dose 4
Feeling: Fair

Adult check-in
2023-02-11
Health check-in — 3 month, dose 4
Feeling: Fair

Adult check-in
2023-05-13
Survey response — 6 month, dose 4
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11 · check-in answers available
2023-05-13
Report sent to call center — 6 month, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2023-05-15
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-13	Pfizer-BioNTech
2	2021-06-10	Pfizer-BioNTech
3	2022-03-04	Pfizer-BioNTech	No
4	2022-11-12	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-27	Successful 2022-04-28	Does not wish to fill out VAERS report
2023-05-13	Successful 2023-05-15	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 8

Systemic reaction (other): Numb tongue

Symptoms: Raised welt-like rash at injection site. 2inch diameter,hot, very itchy. Started day 8. Benedryl helped. Still there but faded

Release 9

Systemic reaction (other): Still bruised at injection site.

Symptoms: Flare of autoimmune disorder of esophagus.

Symptoms: Autoimmune esophagitis is still flaring.

Symptoms: Hyper parathyroid Flare of autoimmune diseases.

Release 10

Symptoms: Joint and muscle pain

Release 11

Systemic reaction (other): Tongue felt thick right after vaccination.

Symptoms: Leg cramps, flare of autoimmune esophagitis.

Symptoms: Increased migraine headaches

Release 12

Systemic reaction (other): Numb lips and tongue

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	Hyperparathyroidism	·	·	✓
SD	Injection site pruritus	✓	✓	✓
SD	Injection site rash	✓	✓	✓
SD	Injection site warmth	✓	✓	✓
SD	Migraine	·	·	✓
SD	Muscle spasms	·	·	✓
SD	Myalgia	·	·	✓
SD	Oesophagitis	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Self-medication	✓	✓	✓
SRO	Hypoaesthesia oral	✓	✓	✓
SRO	Immediate post-injection reaction	·	·	✓
SRO	Injection site bruising	✓	✓	✓
SRO	Tongue disorder	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release